DKK1 and Tako-tsubo cardiomyopathy: As a result of DKK-1’s functional role in regulating inflammation mediated by platelets and its contribution to plaque destabilization, it can be hypothesized that DKK-1 could be used as a risk predictor and as a potential target for future therapies in ASc.